Author:
Ural A. Ugur,Yilmaz M. Ilker,Avcu Ferit,Yalcin Atilla
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis.N Engl J Med. 1983;309:288–296.
2. Arad Y, Ramakrishnan E, Ginsberg HN. Lovastatin therapy reduces low density lipoprotein apo B levels in subjects with combined hyperlipidemia by reducing production of apoB-containing lipoproteins: implications for pathophysiology of apoB production.J Lipid Res. 1990;31:567–582.
3. Stephard J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.N Engl J Med. 1995;333:1301–1307.
4. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet. 1994;3441:383–389.
5. Beigel Y, Fuchs J, Snir M, Lurie Y, Green P, Djaldetti M. Lovastatin therapy in heterozygous familial hypercholesterolemic patients: effect on blood rheology and fibrinogen levels.J Intern Med. 1991; 230:23–27.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献